Core Laboratories (NYSE:CLB) had its target price reduced by analysts at RBC Capital from $130.00 to $105.00 in a report released on Thursday, AnalystRatings.Net reports. The firm presently has an “outperform” rating on the stock. RBC Capital’s price objective suggests a potential upside of 6.71% from the stock’s previous close.

Several other brokerages have also recently issued reports on CLB. SunTrust decreased their price objective on Core Laboratories from $123.00 to $116.00 in a report on Wednesday, October 7th. Guggenheim raised Core Laboratories from a “neutral” rating to a “buy” rating and set a $135.00 target price on the stock in a research report on Monday, November 30th. Cowen and Company cut their target price on Core Laboratories from $90.00 to $86.00 and set a “market perform” rating on the stock in a research report on Monday, October 26th. Iberia Capital reissued an “outperform” rating and set a $140.00 target price on shares of Core Laboratories in a research report on Saturday, October 24th. Finally, Morgan Stanley reissued an “overweight” rating and set a $148.00 target price on shares of Core Laboratories in a research report on Saturday, October 24th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $116.75.

Other institutional investors have recently bought and sold shares of the company. State Board of Administration of Florida Retirement System purchased a new position in Core Laboratories during the fourth quarter worth about $256,000. Creative Planning increased its position in Core Laboratories by 85.9% in the fourth quarter. Creative Planning now owns 2,597 shares of the company’s stock worth $282,000 after buying an additional 1,200 shares during the last quarter. Parametrica Management purchased a new position in Core Laboratories during the fourth quarter worth about $301,000. CWM LLC increased its position in Core Laboratories by 38.7% in the fourth quarter. CWM LLC now owns 2,966 shares of the company’s stock worth $323,000 after buying an additional 827 shares during the last quarter. Finally, World Asset Management Inc increased its position in Core Laboratories by 3.3% in the fourth quarter. World Asset Management Inc now owns 3,053 shares of the company’s stock worth $332,000 after buying an additional 97 shares during the last quarter.

Core Laboratories (NYSE:CLB) traded down 2.85% on Thursday, hitting $95.60. 644,420 shares of the company were exchanged. The company has a market capitalization of $4.06 billion and a price-to-earnings ratio of 35.71. The stock has a 50 day moving average of $102.52 and a 200 day moving average of $109.58. Core Laboratories has a 52 week low of $84.50 and a 52 week high of $134.87.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings data on Wednesday, January 27th. The company reported $0.65 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.65. The firm had revenue of $182.70 million for the quarter, compared to analysts’ expectations of $179.48 million. During the same period last year, the company earned $1.54 earnings per share. The firm’s revenue was down 34.4% on a year-over-year basis. Analysts predict that Core Laboratories will post $2.38 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, February 19th. Stockholders of record on Friday, January 22nd will be given a dividend of $0.55 per share. This is a positive change from Core Laboratories’s previous quarterly dividend of $0.32. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date is Wednesday, January 20th.

Core Laboratories N.V. (NYSE:CLB) is a provider of proprietary and patented reservoir description, production enhancement and reservoir management services to the oil and gas industry. These services and products are directed toward enabling its clients to improve reservoir performance and increase oil and gas recovery from their producing fields. The Company operates in three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Company provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry.

12 Month Chart for NYSE:CLB

Frustrated with your broker? Are you tired of paying high fees? Do you feel like you are getting ripped off by your stock broker? It's time for a change. Find out which brokerage is best for your personal trading style at the InvestorPlace Broker Center. Compare brokers at a glance in the InvestorPlace Broker Center (Click Here).

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.